Skip to main content

previous disabled Page of 2
and
  1. Article

    Open Access

    Automated database-guided expert-supervised orientation for immunophenotypic diagnosis and classification of acute leukemia

    Precise classification of acute leukemia (AL) is crucial for adequate treatment. EuroFlow has previously designed an AL orientation tube (ALOT) to guide towards the relevant classification panel (T-cell acute ...

    L Lhermitte, E Mejstrikova, A J van der Sluijs-Gelling, G E Grigore, L Sedek in Leukemia (2018)

  2. No Access

    Article

    TCRα rearrangements identify a subgroup of NKL-deregulated adult T-ALLs associated with favorable outcome

    T-cell acute lymphoblastic leukemia (T-ALL) results from leukemic transformation of T-cell precursors arrested at specific differentiation stages, including an ‘early-cortical’ thymic maturation arrest charact...

    P Villarese, C Lours, A Trinquand, S Le Noir, M Belhocine, L Lhermitte in Leukemia (2018)

  3. No Access

    Article

    Age-related clinical and biological features of PTEN abnormalities in T-cell acute lymphoblastic leukaemia

    The tumour suppressor gene PTEN is commonly altered in T-cell acute lymphoblastic leukaemia but its prognostic impact is still debated. We screened a cohort of 573 fully characterised adult and paediatric T-cell ...

    M Tesio, A Trinquand, P Ballerini, G Hypolite, L Lhermitte, A Petit, N Ifrah in Leukemia (2017)

  4. Article

    Open Access

    Monitoring molecular response in adult T-cell leukemia by high-throughput sequencing analysis of HTLV-1 clonality

    M Artesi, A Marçais, K Durkin, N Rosewick, V Hahaut, F Suarez, A Trinquand in Leukemia (2017)

  5. No Access

    Article

    CBFβ-SMMHC regulates ribosomal gene transcription and alters ribosome biogenesis

    G Cordonnier, A Mandoli, A Radhouane, G Hypolite, L Lhermitte, M Belhocine in Leukemia (2017)

  6. No Access

    Article

    Baboon envelope pseudotyped lentiviral vectors: a highly efficient new tool to genetically manipulate T-cell acute lymphoblastic leukaemia-initiating cells

    C Costa, G Hypolite, O Bernadin, C Lévy, F-L Cosset, V Asnafi, E Macintyre in Leukemia (2017)

  7. Article

    Open Access

    Acute lymphoblastic leukemia relapsing after first-line pediatric-inspired therapy: a retrospective GRAALL study

    The outcome of adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia (Ph− ALL) relapsing after pediatric-inspired front-line therapy is ill known. Here 229 relapsing Ph− ALL younger...

    A Desjonquères, P Chevallier, X Thomas, F Huguet, T Leguay in Blood Cancer Journal (2016)

  8. No Access

    Article

    Oncogenic PTEN functions and models in T-cell malignancies

    PTEN is a protein phosphatase that is crucial to prevent the malignant transformation of T-cells. Although a numerous mechanisms regulate its expression and function, they are often altered in T-cell acute lym...

    M Tesio, A Trinquand, E Macintyre, V Asnafi in Oncogene (2016)

  9. No Access

    Article

    Flow cytometry and IG/TCR quantitative PCR for minimal residual disease quantitation in acute lymphoblastic leukemia: a French multicenter prospective study on behalf of the FRALLE, EORTC and GRAALL

    Minimal residual disease (MRD) quantification is widely used for therapeutic stratification in pediatric acute lymphoblastic leukemia (ALL). A robust, reproducible, sensitivity of at least 0.01% has been achie...

    R Garand, K Beldjord, H Cavé, C Fossat, I Arnoux, V Asnafi, Y Bertrand in Leukemia (2013)

  10. No Access

    Article

    Receptor kinase profiles identify a rationale for multitarget kinase inhibition in immature T-ALL

    Constitutively activated FLT3 signaling is common in acute myeloid leukemia, and is currently under evaluation for targeted therapy, whereas little data is available in T-cell acute lymphoblastic leukemia (T-A...

    L Lhermitte, R Ben Abdelali, P Villarèse, N Bedjaoui, V Guillemot, A Trinquand in Leukemia (2013)

  11. Article

    Open Access

    EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenoty** of normal, reactive and malignant leukocytes

    Most consensus leukemia & lymphoma antibody panels consist of lists of markers based on expert opinions, but they have not been validated. Here we present the validated EuroFlow 8-color antibody panels for imm...

    J J M van Dongen, L Lhermitte, S Böttcher, J Almeida, V H J van der Velden in Leukemia (2012)

  12. Article

    Open Access

    EuroFlow standardization of flow cytometer instrument settings and immunophenoty** protocols

    The EU-supported EuroFlow Consortium aimed at innovation and standardization of immunophenoty** for diagnosis and classification of hematological malignancies by introducing 8-color flow cytometry with fully...

    T Kalina, J Flores-Montero, V H J van der Velden, M Martin-Ayuso, S Böttcher in Leukemia (2012)

  13. Article

    Caspase-activated ROCK-1 allows erythroblast terminal maturation independently of cytokine-induced Rho signaling

    Stem cell factor (SCF) and erythropoietin are strictly required for preventing apoptosis and stimulating proliferation, allowing the differentiation of erythroid precursors from colony-forming unit-E to the po...

    A-S Gabet, S Coulon, A Fricot, J Vandekerckhove, Y Chang in Cell Death & Differentiation (2011)

  14. No Access

    Article

    Standardized MRD quantification in European ALL trials: Proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18–20 September 2008

    Assessment of minimal residual disease (MRD) has acquired a prominent position in European treatment protocols for patients with acute lymphoblastic leukemia (ALL), on the basis of its high prognostic value fo...

    M Brüggemann, A Schrauder, T Raff, H Pfeifer, M Dworzak, O G Ottmann, V Asnafi in Leukemia (2010)

  15. No Access

    Article

    Human erythroleukemia: is the two-hit model of mouse leukemogenesis valid in human disease?

    S Coulon, J Vandekerckhove, M Dussiot, C Callens, F Suarez, J Kersual, V Asnafi in Leukemia (2007)

  16. No Access

    Article

    Most immature T-ALLs express Ra-IL3 (CD123): possible target for DT-IL3 therapy

    L Lhermitte, A de Labarthe, C Dupret, H Lapillonne, C Millien, J Landman-Parker in Leukemia (2006)

  17. No Access

    Article

    HOXA cluster deregulation in T-ALL associated with both a TCRD-HOXA and a CALM-AF10 chromosomal translocation

    J Bergeron, E Clappier, B Cauwelier, N Dastugue, C Millien, E Delabesse in Leukemia (2006)

  18. No Access

    Article

    Prediction of relapse by day 100 BCR-ABL quantification after allogeneic stem cell transplantation for chronic myeloid leukemia

    Chronic myeloid leukemia (CML) relapse after allogeneic stem cell transplantation (SCT) is a relatively frequent situation, which is correlated to disease status, time from diagnosis to transplant and T-cell d...

    V Asnafi, M-T Rubio, E Delabesse, E Villar, F Davi, G Damaj, I Hirsch, N Dhédin in Leukemia (2006)

  19. No Access

    Article

    IgH/TCR rearrangements are common in MLL translocated adult AML and suggest an early T/myeloid or B/myeloid maturation arrest, which correlates with the MLL partner

    C Dupret, V Asnafi, D Leboeuf, C Millien, R Ben Abdelali, C Preudhomme in Leukemia (2005)

  20. No Access

    Article

    CALM-AF10+ T-ALL expression profiles are characterized by overexpression of HOXA and BMI1 oncogenes

    The t(10;11)(p13;q14–21) is found in T-ALL and acute myeloid leukemia and fuses CALM (Clathrin-Assembly protein-like Lymphoid-Myeloid leukaemia gene) to AF10. In order to gain insight into the transcriptional con...

    W A Dik, W Brahim, C Braun, V Asnafi, N Dastugue, O A Bernard, J J M van Dongen in Leukemia (2005)

previous disabled Page of 2